Recent Advances in Understanding of Alzheimer’s Disease Progression Through Mass Spectrometry-Based Metabolomics
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aldámiz-Echevarría L, Andrade F (2012) Asymmetric dimethylarginine, endothelial dysfunction and renal disease. Int J Mol Sci 13:11288–11311. https://doi.org/10.3390/ijms130911288
Almanza-Aguilera E, Brunius C, Bernal-Lopez MR et al (2018) Impact in plasma metabolome as effect of lifestyle intervention for weight-loss reveals metabolic benefits in metabolically healthy obese women. J Proteome Res 17:2600–2610. https://doi.org/10.1021/acs.jproteome.8b00042
Amtul Z, Uhrig M, Wang L, Rozmahel RF, Beyreuther K (2012) Detrimental effects of arachidonic acid and its metabolites in cellular and mouse models of Alzheimer’s disease: structural insight. Neurobiol Aging 33(831):e821–831. https://doi.org/10.1016/j.neurobiolaging.2011.07.014
Arakawa T, Timasheff S (1985) The stabilization of proteins by osmolytes. Biophys J 47:411–414. https://doi.org/10.1016/S0006-3495(85)83932-1
Asif M, Louis Soiza R, McEvoy M, Mangoni A (2013) Asymmetric dimethylarginine: a possible link between vascular disease and dementia. Curr Alzheimer Res 10:347–356. https://doi.org/10.2174/1567205011310040001
Auld DS, Kornecook TJ, Bastianetto S, Quirion R (2002) Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 68:209–245. https://doi.org/10.1016/s0301-0082(02)00079-5
Beckonert O, Keun HC, Ebbels TM et al (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2:2692. https://doi.org/10.1038/nprot.2007.376
Bergau N, Maul S, Rujescu D, Simm A, Navarrete Santos A (2019) Reduction of glycolysis intermediate concentrations in the cerebrospinal fluid of Alzheimers Disease patients. Front Neurosci 13:871. https://doi.org/10.3389/fnins.2019.00871
Bingham EM, Hopkins D, Smith D et al (2002) The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. Diabetes 51:3384–3390. https://doi.org/10.2337/diabetes.51.12.3384
Calsolaro V, Edison P (2016) Alterations in glucose metabolism in Alzheimer’s disease. Recent Pat Endocr Metab Immune Drug Discov 10:31–39. https://doi.org/10.2174/1872214810666160615102809
Cech NB, Enke CG (2001) Practical implications of some recent studies in electrospray ionization fundamentals. Mass Spectrom Rev 20:362–387. https://doi.org/10.1002/mas.10008
Chetwynd AJ, Dunn WB, Rodriguez-Blanco G (2017) Collection and preparation of clinical samples for metabolomics. Metabolomics: from fundamentals to clinical applications. Springer, Berlin, pp 19–44. https://doi.org/10.1007/978-3-319-47656-8_2
Ciavardelli D, Piras F, Consalvo A et al (2016) Medium-chain plasma acylcarnitines, ketone levels, cognition, and gray matter volumes in healthy elderly, mildly cognitively impaired, or Alzheimer’s disease subjects. Neurobiol Aging 43:1–12. https://doi.org/10.1016/j.neurobiolaging.2016.03.005
Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM (1998) Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55:1449–1455. https://doi.org/10.1001/archneur.55.11.1449
Clemente G, van Waarde A, Antunes I, Dömling A, Elsinga P (2020) Arginase as a potential biomarker of disease progression: a molecular imaging perspective. Int J Mol Sci 21:5291. https://doi.org/10.3390/ijms21155291
Coyle JT, Price DL, Delong MR (1983) Alzheimer’s disease: a disorder of cortical cholinergic innervation. Science 219:1184–1190. https://doi.org/10.1126/science.6338589
Craft S, Asthana S, Cook DG et al (2003) Insulin dose–response effects on memory and plasma amyloid precursor protein in Alzheimer’s disease: interactions with apolipoprotein E genotype. Psychoneuroendocrinology 28:809–822. https://doi.org/10.1016/s0306-4530(02)00087-2
Darvesh S, Walsh R, Martin E (2007) Homocysteine thiolactone and human cholinesterases. Cell Mol Neurobiol 27:33–48. https://doi.org/10.1007/s10571-006-9114-0
Davies P, Maloney A (1976) Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet 308:1403. https://doi.org/10.1016/s0140-6736(76)91936-x
de la Monte SM (2009) Insulin resistance and Alzheimer’s disease. BMB Rep 42:475. https://doi.org/10.5483/bmbrep.2009.42.8.475
de Leeuw FA, Peeters CF, Kester MI et al (2017) Blood-based metabolic signatures in Alzheimer’s disease. Alzheimers Dement (amst) 8:196–207. https://doi.org/10.1016/j.dadm.2017.07.006
de Souza Wyse AT, Bavaresco CS, Hagen MEK et al (2001) In vitro stimulation of oxidative stress in cerebral cortex of rats by the guanidino compounds accumulating in hyperargininemia. Brain Res 923:50–57. https://doi.org/10.1016/s0006-8993(01)03197-3
Delwel S, Binnekade TT, Perez RS, Hertogh CM, Scherder EJ, Lobbezoo F (2018) Oral hygiene and oral health in older people with dementia: a comprehensive review with focus on oral soft tissues. Clin Oral Investig 22:93–108. https://doi.org/10.1007/s00784-017-2264-2
Delwing-de Lima D, Wollinger LF, Casagrande ACM et al (2010) Guanidino compounds inhibit acetylcholinesterase and butyrylcholinesterase activities: effect neuroprotector of vitamins E plus C. Int J Dev Neurosci 28:465–473. https://doi.org/10.1016/j.ijdevneu.2010.06.008
Dolci GA, Damanti S, Scortichini V et al (2017) Alzheimer’s disease diagnosis: discrepancy between clinical, neuroimaging, and cerebrospinal fluid biomarkers criteria in an Italian cohort of geriatric outpatients: a retrospective cross-sectional study. Front Med 4:203. https://doi.org/10.3389/fmed.2017.00203
dos Santos PA, David F, Vanhoenacker G, Sandra P (2009) The acetonitrile shortage: is reversed HILIC with water an alternative for the analysis of highly polar ionizable solutes? J Sep Sci 32:2001–2007. https://doi.org/10.1002/jssc.200900272
Drachman DA, Leavitt J (1974) Human memory and the cholinergic system: a relationship to aging? Arch Neurol 30:113–121. https://doi.org/10.1001/archneur.1974.00490320001001
Emwas A-HM (2015) The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research. Springer, In Metabonomics, pp 161–193. https://doi.org/10.1007/978-1-4939-2377-9_13
Etgen T, Chonchol M, Förstl H, Sander D (2012) Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis. Am J Nephrol 35:474–482. https://doi.org/10.1159/000338135
Feng Y, Chen B, Yu Q et al (2019) Isobaric multiplex labeling reagents for carbonyl-containing compound (SUGAR) tags: a probe for quantitative glycomic analysis. Anal Chem 91:3141–3146. https://doi.org/10.1021/acs.analchem.8b05757
Frances A, First MB, Pincus HA (1995) DSM-IV guidebook. American Psychiatric Association
Francis PT (2003) Glutamatergic systems in Alzheimer’s disease. Int J Geriatr Psychiatry 18:S15–S21. https://doi.org/10.1002/gps.934
Gao SS, Chu CH, Young FYF (2020) Oral health and care for elderly people with Alzheimer’s disease. Int J Environ Res Public Health 17:5713. https://doi.org/10.3390/ijerph17165713
Gaugler J, James B, Johnson T, Marin A, Weuve J (2019) 2019 Alzheimer’s disease facts and figures. Alzheimers Dement 15:321–387. https://doi.org/10.1016/j.jalz.2019.01.010
González-Domínguez R, García A, García-Barrera T, Barbas C, Gómez-Ariza JL (2014) Metabolomic profiling of serum in the progression of Alzheimer’s disease by capillary electrophoresis–mass spectrometry. Electrophoresis 35:3321–3330. https://doi.org/10.1002/elps.201400196
Graham SF, Chevallier OP, Elliott CT et al (2015) Untargeted metabolomic analysis of human plasma indicates differentially affected polyamine and L-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer’s disease. PLoS ONE 10:e0119452. https://doi.org/10.1371/journal.pone.0119452
Habartová L, Hrubešová K, Syslová K et al (2019) Blood-based molecular signature of Alzheimer’s disease via spectroscopy and metabolomics. Clin Biochem 72:58–63. https://doi.org/10.1016/j.clinbiochem.2019.04.004
Hahne H, Neubert P, Kuhn K et al (2012) Carbonyl-reactive tandem mass tags for the proteome-wide quantification of N-linked glycans. Anal Chem 84:3716–3724. https://doi.org/10.1021/ac300197c
Hajjar I, Liu C, Jones DP, Uppal K (2020) Untargeted metabolomics reveal dysregulations in sugar, methionine, and tyrosine pathways in the prodromal state of AD. Alzheimers Dement (amst) 12:12064. https://doi.org/10.1002/dad2.12064
Hansmannel F, Sillaire A, Kamboh MI et al (2010) Is the urea cycle involved in Alzheimer’s disease? J Alzheimers Dis 21:1013–1021. https://doi.org/10.3233/JAD-2010-100630
Hao L, Greer T, Page D et al (2016) In-depth characterization and validation of human urine metabolomes reveal novel metabolic signatures of lower urinary tract symptoms. Sci Rep 6:1–11. https://doi.org/10.1038/srep30869
Hao L, Johnson J, Lietz CB et al (2017) Mass defect-based N, N-dimethyl leucine labels for quantitative proteomics and amine metabolomics of pancreatic cancer cells. Anal Chem 89:1138–1146. https://doi.org/10.1021/acs.analchem.6b03482
Huan T, Tran T, Zheng J et al (2018) Metabolomics analyses of saliva detect novel biomarkers of Alzheimer’s disease. J Alzheimers Dis 65:1401–1416. https://doi.org/10.3233/JAD-180711
Iyer R, Jenkinson C, Vockley J, Kern R, Grody W, Cederbaum S (1998) The human arginases and arginase deficiency. J Inherit Metab Dis 21:86–100. https://doi.org/10.1023/a:1005313809037
Jack CR Jr, Bennett DA, Blennow K et al (2018) NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement 14:535–562. https://doi.org/10.1016/j.jalz.2018.02.018
Kamleh MA, Dow JA, Watson DG (2009) Applications of mass spectrometry in metabolomic studies of animal model and invertebrate systems. Brief Funct Genomic Proteomic 8:28–48. https://doi.org/10.1093/bfgp/eln052
Kanemaru K, Kanemaru A, Murayama S (2016) Association between renal functions and csf biomarkers in alzheimer’s disease. Alzheimers Dement 7:P665. https://doi.org/10.1016/j.jalz.2016.06.1508
Kao Y-C, Ho P-C, Tu Y-K, Jou I, Tsai K-J (2020) Lipids and Alzheimer’s disease. Int J Mol Sci 21:1505. https://doi.org/10.3390/ijms21041505
Kashiwaya Y, King MT, Veech RL (1997) Substrate signaling by insulin: a ketone bodies ratio mimics insulin action in heart. Am J Cardiol 80:50A–64A. https://doi.org/10.1016/s0002-9149(97)00458-x
Kim PS, Iyer RK, Lu KV et al (2002) Expression of the liver form of arginase in erythrocytes. Mol Genet Metab 76:100–110. https://doi.org/10.1016/s1096-7192(02)00034-3
Kim M, Snowden S, Suvitaival T et al (2019) Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer’s Disease biomarker discovery cohort. Alzheimers Dement 15:817–827. https://doi.org/10.1016/j.jalz.2019.03.004
Krikorian R, Shidler MD, Dangelo K, Couch SC, Benoit SC, Clegg DJ (2012) Dietary ketosis enhances memory in mild cognitive impairment. Neurobiol Aging 33(425):e419–425. https://doi.org/10.1016/j.neurobiolaging.2010.10.006
Lawton KA, Berger A, Mitchell M, et al (2008) Analysis of the adult human plasma metabolome. Pharmacogenomics 9(4):383–397. https://doi.org/10.2217/14622416.9.4.383
Li L, Hölscher C (2007) Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev 56:384–402. https://doi.org/10.1016/j.brainresrev.2007.09.001
Li S, Jin Y, Wang J et al (2016) Urinary profiling of cis-diol-containing metabolites in rats with bisphenol A exposure by liquid chromatography-mass spectrometry and isotope labeling. Analyst 141:1144–1153. https://doi.org/10.1039/c5an02195b
Liland KH (2011) Multivariate methods in metabolomics–from pre-processing to dimension reduction and statistical analysis. Trends Analyt Chem 30:827–841. https://doi.org/10.1016/j.trac.2011.02.007
Liu P, Fleete MS, Jing Y et al (2014) Altered arginine metabolism in Alzheimer’s disease brains. Neurobiol Aging 35:1992–2003. https://doi.org/10.1016/j.neurobiolaging.2014.03.013
Mapstone M, Cheema AK, Fiandaca MS et al (2014) Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med 20:415–418. https://doi.org/10.1038/nm.3466
Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D (2008) Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics*. J Lipid Res 49:1137–1146. https://doi.org/10.1194/jlr.D700041-JLR200
McAdams-DeMarco MA, Bae S, Chu N et al (2017) Dementia and Alzheimer’s disease among older kidney transplant recipients. J Am Soc Nephrol 28:1575–1583. https://doi.org/10.1681/ASN.2016080816
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–939. https://doi.org/10.1212/wnl.34.7.939
Misra BB (2021) New software tools, databases, and resources in metabolomics: updates from 2020. Metabolomics 17:1–24. https://doi.org/10.1007/s11306-021-01796-1
Moreira PI (2012) Alzheimer’s disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin. J Alzheimers Dis 30:S199–S215. https://doi.org/10.3233/JAD-2011-111127
Mushtaq MY, Choi YH, Verpoorte R, Wilson EG (2014) Extraction for metabolomics: access to the metabolome. Phytochem Anal 25:291–306. https://doi.org/10.1002/pca.2505
Musunuri S, Wetterhall M, Ingelsson M et al (2014) Quantification of the brain proteome in Alzheimer’s disease using multiplexed mass spectrometry. J Proteome Res 13:2056–2068. https://doi.org/10.1021/pr401202d
Nabetani T, Makino A, Hullin-Matsuda F et al (2011) Multiplex analysis of sphingolipids using amine-reactive tags (iTRAQ). J Lipid Res 52:1294–1302. https://doi.org/10.1194/jlr.D014621
Nasaruddin ML, Hölscher C, Kehoe P, Graham SF, Green BD (2016) Wide-ranging alterations in the brain fatty acid complement of subjects with late Alzheimer’s disease as detected by GC–MS. Am J Transl Res 8:154
Naser FJ, Mahieu NG, Wang L, Spalding JL, Johnson SL, Patti GJ (2018) Two complementary reversed-phase separations for comprehensive coverage of the semipolar and nonpolar metabolome. Anal Bioanal Chem 410:1287–1297. https://doi.org/10.1007/s00216-017-0768-x
National Institute on Aging (2017) How is Alzheimer's disease diagnosed?
Niedzwiecki MM, Walker DI, Howell JC et al (2020) High-resolution metabolomic profiling of Alzheimer’s disease in plasma. Ann Clin Transl Neurol 7:36–45. https://doi.org/10.1002/acn3.50956
Nordström A, Want E, Northen T, Lehtiö J, Siuzdak G (2008) Multiple ionization mass spectrometry strategy used to reveal the complexity of metabolomics. Anal Chem 80:421–429. https://doi.org/10.1021/ac701982e
Ott A, Stolk R, Van Harskamp F, Pols H, Hofman A, Breteler M (1999) Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53:1937–1937. https://doi.org/10.1212/wnl.53.9.1937
Park CR, Seeley RJ, Craft S, Woods SC (2000) Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol Behav 68:509–514. https://doi.org/10.1016/s0031-9384(99)00220-6
Peña-Bautista C, Roca M, Hervás D et al (2019) Plasma metabolomics in early Alzheimer’s disease patients diagnosed with amyloid biomarker. J Proteomics 200:144–152. https://doi.org/10.1016/j.jprot.2019.04.008
Poulin R, Pelletier G, Pegg A (1995) Induction of apoptosis by excessive polyamine accumulation in ornithine decarboxylase-overproducing L1210 cells. Biochem J 311:723–727. https://doi.org/10.1042/bj3110723
Qian W, Schweizer T, Munoz D, Fischer CE (2016) O3–04-06: Misdiagnosis of Alzheimer’s disease: inconsistencies between clinical diagnosis and neuropathological confirmation. Alzheimers Dement 12:293–293. https://doi.org/10.1016/j.jalz.2016.06.529
Radić J, Ljutić D, Radić M, Kovačić V, Dodig-Ćurković K, Šain M (2011) Kidney transplantation improves cognitive and psychomotor functions in adult hemodialysis patients. Am J Nephrol 34:399–406. https://doi.org/10.1159/000330849
Ramautar R, Somsen GW, de Jong GJ (2009) CE-MS in metabolomics. Electrophoresis 30:276–291. https://doi.org/10.1002/elps.200800512
Reger MA, Henderson ST, Hale C et al (2004) Effects of β-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging 25:311–314. https://doi.org/10.1016/S0197-4580(03)00087-3
Reger M, Watson G, Green P et al (2008) Intranasal insulin improves cognition and modulates β-amyloid in early AD. Neurology 70:440–448. https://doi.org/10.1212/01.WNL.0000265401.62434.36
Rosales-Corral S, Tan D-X, Manchester L, Reiter RJ (2015) Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stress. Oxid Med Cell Longev 2015:1–14. https://doi.org/10.1155/2015/985845
Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med 8:595–608. https://doi.org/10.15252/emmm.201606210
Seshadri S, Beiser A, Selhub J et al (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 346:476–483. https://doi.org/10.1056/NEJMoa011613
Shi Y, Liu Z, Shen Y, Zhu H (2018) A novel perspective linkage between kidney function and Alzheimer’s disease. Front Cell Neurosci 12:384. https://doi.org/10.3389/fncel.2018.00384
Shippy DC, Wilhelm C, Viharkumar PA, Raife TJ, Ulland TK (2020) β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology. J Neuroinflammation 17:1–12. https://doi.org/10.1186/s12974-020-01948-5
Sidhu D, Naugler C (2012) Fasting time and lipid levels in a community-based population: a cross-sectional study. Arch Intern Med 172:1707–1710. https://doi.org/10.1001/archinternmed.2012.3708
Snowden SG, Ebshiana AA, Hye A et al (2017) Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: a nontargeted metabolomic study. PLoS Med 14:1002266. https://doi.org/10.1371/journal.pmed.1002266
Soga T, Imaizumi M (2001) Capillary electrophoresis method for the analysis of inorganic anions, organic acids, amino acids, nucleotides, carbohydrates and other anionic compounds. Electrophoresis 22:3418–3425. https://doi.org/10.1002/1522-2683(200109)22:16
Steckel A, Schlosser G (2019) An organic chemist’s guide to electrospray mass spectrometric structure elucidation. Molecules 24:611. https://doi.org/10.3390/molecules24030611
Steen E, Terry BM, Rivera J et al (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease–is this type 3 diabetes? J Alzheimers Dis 7:63–80. https://doi.org/10.3233/jad-2005-7107
Stepler KE, Mahoney ER, Kofler J, Hohman TJ, Lopez OL, Robinson RA (2020) Inclusion of African American/Black adults in a pilot brain proteomics study of Alzheimer’s disease. Neurobiol Dis 146:105129. https://doi.org/10.1016/j.nbd.2020.105129
Sun C, Gao M, Wang F et al (2020) Serum metabolomic profiling in patients with Alzheimer disease and amnestic mild cognitive impairment by GC/MS. Biomed Chromatogr 34:4875. https://doi.org/10.1002/bmc.4875
Tautenhahn R, Böttcher C, Neumann S (2008) Highly sensitive feature detection for high resolution LC/MS. BMC Bioinformatics 9:1–16. https://doi.org/10.1186/1471-2105-9-504
Teerlink T, Nijveldt RJ, De Jong S, Van Leeuwen PA (2002) Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 303:131–137. https://doi.org/10.1006/abio.2001.5575
Toraño JS, Ramautar R, de Jong G (2019) Advances in capillary electrophoresis for the life sciences. J Chromatogr B Biomed Sci Appl 1118:116–136. https://doi.org/10.1016/j.jchromb.2019.04.020
Trillo L, Das D, Hsieh W et al (2013) Ascending monoaminergic systems alterations in Alzheimer’s disease. Translating basic science into clinical care. Neurosci Biobehav Rev 37:1363–1379. https://doi.org/10.1016/j.neubiorev.2013.05.008
Tsugawa H, Ikeda K, Takahashi M et al (2020) A lipidome atlas in MS-DIAL 4. Nat Biotechnol 38:1159–1163. https://doi.org/10.1038/s41587-020-0531-2
Tynkkynen J, Chouraki V, van der Lee SJ et al (2018) Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer’s disease: a prospective study in eight cohorts. Alzheimers Dement 14:723–733. https://doi.org/10.1016/j.jalz.2018.01.003
van der Velpen V, Teav T, Gallart-Ayala H et al (2019) Systemic and central nervous system metabolic alterations in Alzheimer’s disease. Alzheimers Res Ther 11:93. https://doi.org/10.1186/s13195-019-0551-7
Verclytte S, Lopes R, Lenfant P et al (2016) Cerebral hypoperfusion and hypometabolism detected by arterial spin labeling MRI and FDG-PET in early-onset Alzheimer’s disease. J Neuroimaging 26:207–212. https://doi.org/10.1111/jon.12264
Vilela TC, Scaini G, Furlanetto CB et al (2017) Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease. Metab Brain Dis 32:115–122. https://doi.org/10.1007/s11011-016-9892-0
Vinaixa M, Samino S, Saez I, Duran J, Guinovart JJ, Yanes O (2012) A guideline to univariate statistical analysis for LC/MS-based untargeted metabolomics-derived data. Metabolites 2:775–795. https://doi.org/10.3390/metabo2040775
Wang Y-F, Fuh J-L, Lirng J-F et al (2015) Cerebrospinal fluid leakage and headache after lumbar puncture: a prospective non-invasive imaging study. Brain 138:1492–1498. https://doi.org/10.1093/brain/awv016
Wilkins JM, Trushina E (2018) Application of metabolomics in Alzheimer’s disease. Front Neurol 8:719. https://doi.org/10.3389/fneur.2017.00719
Williams K, Romano C, Molinoff PB (1989) Effects of polyamines on the binding of [3H] MK-801 to the N-methyl-d-aspartate receptor: pharmacological evidence for the existence of a polyamine recognition site. Mol Pharmacol 36:575–581
Williams JH, Pereira EA, Budge MM, Bradley KM (2002) Minimal hippocampal width relates to plasma homocysteine in community-dwelling older people. Age Ageing 31:440–444. https://doi.org/10.1093/ageing/31.6.440
Wirth M, Schwarz C, Benson G et al (2019) Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline (SmartAge)—study protocol for a randomized controlled trial. Alzheimers Res Ther 11:36. https://doi.org/10.1186/s13195-019-0484-1
Wishart DS, Feunang YD, Marcu A et al (2018) HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res 46:D608–D617. https://doi.org/10.1093/nar/gkx1089
Xiang F, Ye H, Chen R, Fu Q, Li L (2010) N, N-dimethyl leucines as novel isobaric tandem mass tags for quantitative proteomics and peptidomics. Anal Chem 82:2817–2825. https://doi.org/10.1021/ac902778d
Yancey PH, Clark ME, Hand SC, Bowlus RD, Somero GN (1982) Living with water stress: evolution of osmolyte systems. Science 217:1214–1222. https://doi.org/10.1126/science.7112124
Yeung PK (2018) Metabolomics and biomarkers for drug discovery. Metabolites 8(1):11. https://doi.org/10.3390/metabo8010011
Yilmaz A, Ugur Z, Bisgin H et al (2020) Targeted metabolic profiling of urine highlights a potential biomarker panel for the diagnosis of Alzheimer’s disease and mild cognitive impairment: a pilot study. Metabolites 10:357. https://doi.org/10.3390/metabo10090357
Yu Z, Kastenmüller G, He Y et al (2011) Differences between human plasma and serum metabolite profiles. PLoS ONE 6:21230. https://doi.org/10.1371/journal.pone.0021230
Yudkoff M (2017) Interactions in the metabolism of glutamate and the branched-chain amino acids and ketoacids in the CNS. Neurochem Res 42:10–18. https://doi.org/10.1007/s11064-016-2057-z
Zhang C-E, Tian Q, Wei W et al (2008) Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus. Neurobiol Aging 29:1654–1665. https://doi.org/10.1016/j.neurobiolaging.2007.04.015
Zhang Y-q, Tang Y-b, Dammer E et al (2019) Dysregulated urinary arginine metabolism in older adults with amnestic mild cognitive impairment. Front Aging Neurosci 11:90. https://doi.org/10.3389/fnagi.2019.00090
Zhao S, Li L (2020) Chemical derivatization in LC–MS based metabolomics study. TrenDs Analyt Chem 131:115988. https://doi.org/10.1016/j.trac.2020.115988
Zheng X, Smith FB, Aly NA et al (2019) Evaluating the structural complexity of isomeric bile acids with ion mobility spectrometry. Anal Bioanal Chem 411:4673–4682. https://doi.org/10.1007/s00216-019-01869-0
Zhou J, Yin Y (2016) Strategies for large-scale targeted metabolomics quantification by liquid chromatography-mass spectrometry. Analyst 141:6362–6373. https://doi.org/10.1039/c6an01753c